An analysis of Medicaid data of the 60 most popular psychiatric drugs found a hike in medications for depression, anxiety and attention-deficit/hyperactivity disorder. Prescriptions for sertraline, the generic for Zoloft and most common antidepressant, rose 17% in those three years.
Before the COVID-19 pandemic, the utilization of mental health therapies were on the rise, but the pandemic accelerated the trend. According to a recent Census Bureau survey, the percentage of people experiencing anxiety or depression is double prepandemic levels.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
